Show
Sort by
-
Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo
-
Mannose-binding lectin (MBL2) polymorphisms in rheumatoid arthritis (RA) are not associated with susceptibility or radiological progression rate
-
Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis
-
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis
-
Identification of synovial biomarkers of response to treatment in spondyloarthropathy
-
Anti-TNF alpha induced apoptosis contributes to the induction of Autoantibodies but not the decrease of synovial inflammation in spondyloarthropathy (SPA)
-
Anti-TNFalpha induced apoptosis contributes to the induction of autoantibodies but not the decrease of synovial inflammation in spondyloarthropathy
-
Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in Ankylosing spondylitis